Tumour response and radiation-induced lung injury in patients with recurrent small cell lung cancer treated with radiotherapy and concomitant interferon-α

Lung Cancer

Volumn 23, Issue 1, 1999, Pages 39-52

  Halme, Maija ^a   Hallman, Mikko ^b   Ruotsalainen, Tarja ^a   Piilonen, Anneli ^c   Taskinen, Eero ^c   Pekonen, Markku ^d   Maasilta, Paula ^a   Mattson, Karin ^a  

^a Div Pulmon Dis Clin Physiol   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d NONE

Author keywords

IFN ; Lung surfactant; Radiation induced lung injury; Radiotherapy; SCLC; Tumour response

Indexed keywords

ALPHA INTERFERON; CISPLATIN; EPIRUBICIN; ETOPOSIDE; FINNFERON A; IFOSFAMIDE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; RECOMBINANT ALPHA2A INTERFERON; SURFACTANT PROTEIN A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CYTOLOGY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION TEST; LUNG INJURY; LUNG LAVAGE; LUNG SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RECURRENT CANCER;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRONCHOALVEOLAR LAVAGE FLUID; CARCINOMA, SMALL CELL; CELL COUNT; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLYCOPROTEINS; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERLEUKIN-1; LUNG NEOPLASMS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROTEOLIPIDS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; PULMONARY SURFACTANTS; RADIATION PNEUMONITIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033055388     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(98)00092-0     Document Type: Article

References (20)

1. Brown G.P., Iwamoto G.M., Monick M.M., Hunninghake G.W. Cigarette smoking decreases interleukin 1 release by human alveolar macrophages. Am J Physiol. 256:1989;260-264.
2. Chang A.Y.C., Keng P.C. Potentiation of radiation cytotoxicity by recombinant interferons, a phenomenon associated with increased blockage at the G2-M phase of the cell cycle. Cancer Res. 47:1987;4338-4341.
3. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
4. Doyle I.R., Nicholas T.E., Bersten A.D. Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome. Am J Respir Crit Care Med. 152:1995;307-317.
5. Gould M.N., Kakria R.C., Olson S., Borden E.C. Radiosensitization of human bronchogenic carcinoma cells by interferon beta. J Interferon Res. 4:1984;123-128.
6. Gross N.J. Surfactant subtypes in experimental lung damage: radiation pneumonitis. Am J Physiol. 260:1991;302-310.
7. Hallman M., Maasilta P., Kivisaari L., Mattson K. Changes in surfactant in brochoalveolar lavage fluid after hemithorax irradiation in patients with mesothelioma. Am Rev Respir Dis. 141:1990;998-1005.
8. Hallman M., Merritt T.A., Akino T., Bry K. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis. 144:1991;1376-1384.
9. Halme M., Maasilta P., Repo H., Ristola M., Taskinen E., Mattson K.V., Cantell K. Inhaled recombinant interferon-gamma in humans: pharmacokinetics, and effects on chemiluminescence responses of alveolar macrophages and peripheral blood neutrophils and monocytes. Int J Radiat Oncol Biol Phys. 31:1995;93-101.
10. Holsti L.R., Mattson K., Niiranen A., Standertskiöld-Nordenstam C.G., Stenman S., Sovijärvi A., Cantell K. Enhancement of radiation effects by alpha interferon in the treatment of small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 13:1987;1161-1166.
11. Kardamakis D., Gillies N.E., Souhami R.L., Bewerley P.C.L. Recombinant human interferon alpha-2b enhances the radiosensitivity of small cell lung cancer in vitro. Anticancer Res. 9:1989;1041-1044.
12. Late effects consensus conference: RTOG/EORTC. LENT SOMA Tables. Radiother Oncol 1995;35:17-60.
13. Maasilta P., Hallman M., Taskinen E., Kivisaari L., Mattson K. Bronchoalveolar lavage fluid findings following radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 26:1993;117-123.
14. McDonald S., Chang A.Y., Rubin P., Wallenberg J., Kim I.S., Sobel S., Smith J., Keng P., Muhs A. Combined betaseron R (recombinant human interferon beta) and radiation for inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 27:1993;613-619.
15. Miller A.B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 47:1981;207-214.
16. O'Brien-Ladner A., Nelson M.E., Kimler B.F., Wesselius L.J. Release of interleukin-1 by human alveolar macrophages after in vitro irradiation. Radiat Res. 136:1993;37-41.
17. Ortaldo J.R., McCoy J.L. Protective effects of interferon in mice previously exposed to lethal irradiation. Radiat Res. 1:1980;262-266.
18. Rosiello R.A., Merrill W.W., Rockwell S., Carte D., Cooper J.A.D., Care S., Amento E.P. Radiation Pneumonitis. Bronchoalveolar lavage assessment and modulation by a recombinant cytokine. Am Rev Respir Dis. 148:1993;1671-1676.
19. Shaw E.G., Deming R.L., Creagan E.T., Nair S., Su J.Q., Levitt R., Steen P.D., Wiesenfeld M., Mailliard J.A. Pilot study of human recombinant interferon gamma and accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage IIIA/B non small cell lung cancer. Int J Radiat Oncol Biol Phys. 31:1995;827-831.
20. Taskinen E., Tukiainen P., Renkonen R. Bronchoalveolar lavage: influence of cytologic methods on the cellular picture. Acta Cytol. 36:1992;680-686.